In addition to ESCC, increased expression of GPC1 has been reported in pancreatic cancer, breast cancer and glioma and shown to promote the mitogenic, metastatic and angiogenic properties of cancers [6, 21–24]. This evidence concerns the gene GPC1 and breast cancer.